BCV-PA02 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (allo-HCT)
Principal Investigator
Kris M. Mahadeo, MD, MPH
Cellular Therapy Specialist
Protocol Number
IRB:
PRO00119684
NCT:
NCT07387367
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment